Biomarkers in the pharmaceutical industry
Biomarkers in the pharmaceutical industry
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
[...]in the age of targeted therapy in oncology, biomarkers have been used to select patients for treatment with drugs that inhibit the drivers of cancer, including BCR-ABL fusion for Gleevec, HER2 [v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(ERBB2)8] amplification for Herceptin, EML4- ALK (echinoderm microtubule associated prot...
Alternative Titles
Full title
Biomarkers in the pharmaceutical industry
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1667962704
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1667962704
Other Identifiers
ISSN
0009-9147
E-ISSN
1530-8561
DOI
10.1373/clinchem.2014.225284
